Myostatin antisense RNA-mediated muscle growth in normal and cancer cachexia mice
- 22 November 2007
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 15 (3) , 155-160
- https://doi.org/10.1038/sj.gt.3303016
Abstract
Myostatin is a negative regulator of myogenesis, and inactivation of myostatin leads to muscle growth. Here we have used modified RNA oligonucleotides targeting the myostatin mRNA and examined the therapeutic potential in normal and cancer cachexia mouse models. We found that the RNA oligonucleotides could suppress the myostatin expression in vivo, leading to the increase in muscle growth both in normal and cachectic mice. We also established that the effect of myostatin inhibition caused by the RNA oligonucleotides may be through the MyoD pathway, as evidenced by a significant upregulation of MyoD expression. Taken together, these results demonstrate the feasibility using antisense strategy for the treatment of muscle wasting conditions.Keywords
This publication has 18 references indexed in Scilit:
- Smad7 Promotes and Enhances Skeletal Muscle DifferentiationMolecular and Cellular Biology, 2006
- Myostatin short interfering hairpin RNA gene transfer increases skeletal muscle massThe Journal of Gene Medicine, 2006
- Myostatin imposes reversible quiescence on embryonic muscle precursorsDevelopmental Dynamics, 2006
- Skeletal muscle atrophy is associated with an increased expression of myostatin and impaired satellite cell function in the portacaval anastamosis ratAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2004
- REGULATION OF MUSCLE MASS BY MYOSTATINAnnual Review of Cell and Developmental Biology, 2004
- The molecular basis of skeletal muscle atrophyAmerican Journal of Physiology-Cell Physiology, 2004
- Activins, Myostatin and Related TGF-β Family Members as Novel Therapeutic Targets for Endocrine, Metabolic and Immune DisordersCurrent Drug Target - Immune, Endocrine & Metabolic Disorders, 2004
- Modulating skeletal muscle mass by postnatal, muscle‐specific inactivation of the myostatin geneGenesis, 2003
- Functional improvement of dystrophic muscle by myostatin blockadeNature, 2002
- Regulation of skeletal muscle mass in mice by a new TGF-p superfamily memberNature, 1997